Trade

with

POZEN Inc
(NASDAQ: POZN)
AdChoices
=
8.75
0.00
0.00%
After Hours :
8.75
0.00
0.00%

Open

8.87

Previous Close

8.75

Volume (Avg)

267.23k (275.56k)

Day's Range

8.69-8.94

52Wk Range

5.35-9.90

Market Cap.

275.87M

Dividend Rate ( Yield )

-

Beta

2.13

Shares Outstanding

31.53M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 10.32M

    • Net Income

    • -16.71M

    • Market Cap.

    • 275.87M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -4.67

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.13

    • Forward P/E

    • -

    • Price/Sales

    • 12.41

    • Price/Book Value

    • 9.62

    • Price/Cash flow

    • 56.82

      • EBITDA

      • -16.75M

      • Return on Capital %

      • -1.78

      • Return on Equity %

      • -1.99

      • Return on Assets %

      • -1.78

      • Book Value/Share

      • 0.91

      • Shares Outstanding

      • 31.53M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 9.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • 0.88

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 349.40

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • -31.03

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 64.72

            • Pre-Tax Margin

            • -4.67

            • 13.77

            • Net Profit Margin

            • -4.67

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 100.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -115.10

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -114.70

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.33

              • Current Ratio

              • 4.15

              • 1.52

              • Quick Ratio

              • 4.09

              • 0.87

              • Interest Coverage

              • -

              • 6.77

              • Leverage Ratio

              • 1.32

              • 1.91

              • Book Value/Share

              • 0.91

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -243.90

                • 65.79

                • P/E Ratio 5-Year High

                • -375.03

                • 237.47

                • P/E Ratio 5-Year Low

                • -63.59

                • 19.71

                • Price/Sales Ratio

                • 11.72

                • 3.69

                • Price/Book Value

                • 9.09

                • 3.46

                • Price/Cash Flow Ratio

                • 56.82

                • 22.12

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -1.99

                        (4.10)

                      • 7.86

                        (9.58)

                      • Return on Assets %

                        (5-Year Average)

                      • -1.78

                        (4.20)

                      • 4.14

                        (5.54)

                      • Return on Capital %

                        (5-Year Average)

                      • -1.99

                        (4.10)

                      • 5.59

                        (7.66)

                      • Income/Employee

                      • -

                      • 27.79k

                      • Inventory Turnover

                      • -

                      • 1.80

                      • Asset Turnover

                      • 0.38

                      • 0.38

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -16.78M
                      Operating Margin
                      -162.60
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      56.82
                      Ownership

                      Institutional Ownership

                      56.28%

                      Top 10 Institutions

                      36.05%

                      Mutual Fund Ownership

                      14.64%

                      Float

                      66.30%

                      5% / Insider Ownership

                      4.69%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        432,200

                      • 0.00

                      • 1.37

                      • Pru Ret Small Cap Value/Kennedy SP

                      •  

                        418,534

                      • 8.64

                      • 1.33

                      • iShares Russell 2000 (AU)

                      •  

                        409,798

                      • -1.45

                      • 1.55

                      • DFA U.S. Micro Cap Portfolio

                      •  

                        281,541

                      • -4.43

                      • 0.90

                      • Vanguard Extended Market Index Fund

                      •  

                        265,280

                      • 5.61

                      • 0.84

                      • iShares Russell 2000 Growth

                      •  

                        196,770

                      • 0.34

                      • 0.74

                      • DFA U.S. Small Cap Portfolio

                      •  

                        168,990

                      • 0.00

                      • 0.54

                      • Hartford Small Cap Growth HLS Fund

                      •  

                        139,100

                      • 0.00

                      • 0.44

                      • Ariel Discovery Fund

                      •  

                        106,100

                      • -25.86

                      • 0.34

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        94,842

                      • 0.00

                      • 0.30

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Par Capital Management Inc

                      •  

                        2,863,699

                      • -14.68%

                      • 9.12

                      • Ariel Investments, LLC

                      •  

                        1,813,164

                      • -41.14%

                      • 5.77

                      • BlackRock Fund Advisors

                      •  

                        1,287,722

                      • -18.30%

                      • 4.10

                      • Kennedy Capital Management Inc

                      •  

                        1,148,398

                      • +6.77%

                      • 3.66

                      • Dimensional Fund Advisors, Inc.

                      •  

                        972,503

                      • -1.05%

                      • 3.10

                      • Vanguard Group, Inc.

                      •  

                        753,374

                      • +0.78%

                      • 2.40

                      • Contrarius Investment Management Ltd

                      •  

                        662,718

                      • -2.44%

                      • 2.11

                      • Broadfin Capital, LLC

                      •  

                        659,730

                      • -39.09%

                      • 2.10

                      • New York State Common Retirement Fund

                      •  

                        532,794

                      • -19.23%

                      • 1.70

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      Slow Growth

                      Style

                      Small Core

                      POZEN Inc was incorporated in the State of Delaware on September 25, 1996. The Company is a pharmaceutical company focused on transforming medicines that can transform lives. The Company is engaged in developing products that address...more unmet medical needs in the marketplace, obtaining patents for those ideas which the company believes has value in the marketplace, utilizing a small group of talented employees to develop those ideas by working with strategic outsource partners, developing a regulatory pathway with the appropriate agency, and determining how to commercialize its products. The Ccompany has developed Treximet in collaboration with GlaxoSmithKline, or GSK. Treximet is the brand name for the product combining sumatriptan 85 mg, formulated with RT Technology and naproxen sodium 500 mg in a s...moreingle tablet designed for the acute treatment of migraine. The Company has also developed VIMOVO with AstraZeneca AB, or AstraZeneca. VIMOVO (formerly referred to as PN 400) is the brand name for a proprietary fixed dose combination of the PPI esomeprazole magnesium with the NSAID naproxen in a single tablet. The competition for VIMOVO comes from the oral anti-arthritic market, or more specifically the traditional non-selective NSAIDs (such as naproxen and diclofenac), traditional NSAID/gastroprotective agent combination products or combination product packages (such as Arthrotec® and Prevacid® NapraPAC) and the only remaining COX-2 inhibitor, Celebrex®. The Companys product candidates under development are subject to extensive domestic and foreign regulation.lessless

                      Key People

                      Dr. John R. Plachetka,Pharm.D.

                      CEO/Chairman of the Board/Co-Founder/Director/President

                      William L. Hodges

                      CFO/Senior VP, Divisional

                      John E. Barnhardt

                      Chief Accounting Officer/Vice President, Divisional

                      Arthur S. Kirsch

                      Director

                      Kenneth B. Lee,Jr

                      Director

                      • POZEN Inc

                      • 1414 Raleigh Road

                      • Chapel Hill, NC 27517

                      • USA.Map

                      • Phone: +1 919 913-1030

                      • Fax: +1 919 913-1039

                      • pozen.com

                      Incorporated

                      1996

                      Employees

                      16

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: